IGF-1 LR3 (Long Arginine 3-IGF-1) comes in 1mg/vial subcutaneous injections which contain 1mg of Long Arginine 3-IGF-1, and excipients
Results vary based on individual metabolism, dosage, frequency, and lifestyle habits
In a randomised, placebo-controlled double blinded phase 1 study of ascending single doses in healthy overweight humans, cotadutide was shown to be safe and, in common with the GLP-1 analogues, to be associated with dose-dependent gastrointestinal adverse events especially nausea and vomiting
Its also dangerous: the potential risk of giving people who have true blood sugar issues, a false sense of security is unbelievably high
Always inform your GP or prescribing clinician about all medications you're taking to ensure personalised, safe treatment